Arch Biopartners Inc. (OTCMKTS:ACHFF) (CVE:ARCH) was up 5%, and the stock has gained 12% in a week. The company has announced that a scientific team headed by the University of Calgary’s Dr. Danniel Muruve and their partners have published articles in the Science Advances journal highlighting the mechanism of dipeptidase-1 action in acute kidney injury. …
Continue reading “Arch Biopartners Inc. (OTCMKTS:ACHFF) (CVE:ARCH) Stock Gains Momentum: Jumps 5%”